Last reviewed · How we verify
NCT03368079
Utilization of Negative Pressure Suction to Reduce Aspiration in Oropharyngeal Dysphagia
NA trial testing Negative Pressure Suction Catheter in Oropharyngeal Dysphagia in 1 participant. Completed in 9 December 2025.
13 April 2016
Quick facts
| Lead sponsor | University of California, Davis |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 1 |
| Start date | 30 January 2016 |
| Primary completion | 13 April 2016 |
| Estimated completion | 9 December 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Negative Pressure Suction Catheter
Conditions studied
- Oropharyngeal Dysphagia — all drugs for Oropharyngeal Dysphagia →
Sponsor
University of California, Davis
Who can join
18 and older, any sex, with Oropharyngeal Dysphagia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an investigator initiated prospective study to determine whether the use of a negative pressure suction in the hypopharynx will reduce the amount of aspiration during Video Fluoroscopic Swallowing Exam (VFSE) among patients with oropharyngeal dysphagia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03368079
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Oropharyngeal Dysphagia
Currently open trials in the same condition.
- NCT06309602 — Investigation of a Free Water Protocol · NA · recruiting
- NCT06814457 — Nursing Care Bundle on Oral Intake Among Critically Ill Children With Post-Extubation Dysphagia · NA · recruiting
- NCT05421689 — Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia · Phase 1, PHASE2 · active not recruiting
- NCT05278039 — Training Swallowing Initiation During Expiration · NA · recruiting
- NCT04477460 — Effect of Thickened Feeds on Clinical Outcomes in Children With Brief Resolved Unexplained Event · recruiting
Other University of California, Davis trials
Trials by the same sponsor.
- NCT07024498 — Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment · NA · not yet recruiting
- NCT07322133 — Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE) · Phase 4 · recruiting
- NCT07384767 — Efficacy and Safety of Topical Timolol in Secondary Intention Surgical Wounds Healing · Phase 2 · not yet recruiting
- NCT07267494 — Image-Guided Herniorrhaphy Study · NA · not yet recruiting
- NCT04614714 — Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants · Phase 2, PHASE3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03368079 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, Davis
- Last refreshed: 9 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03368079.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing